Thanks SJD,Good valid reasoning steven. Lets hope we see a sniff of something positive within the next couple of weeks and before the dir options expire.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%